EXFORGE HCT
Live / Registered — Registered and renewed (as of 21 Jan 2021)
What this means for you
Registered since 22 Feb 2011. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 22 Feb 2021).
Record
- Serial number
- 77202989
- Registration number
- 3923438
- Mark type
- Stylized text
- Filed
- 11 Jun 2007
- Published for opposition
- 30 Oct 2007
- Registered
- 22 Feb 2011
- Next maintenance due
- 22 Feb 2021
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of and prevention of disorders of the cardio-vascular system
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prior registrations
Prosecution history
- 21 Jan 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 21 Jan 2021 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 21 Jan 2021 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 19 Jan 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Oct 2020 — TEAS SECTION 8 & 9 RECEIVED
- 31 Jan 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
- 31 Jan 2017 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 31 Jan 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Nov 2016 — TEAS SECTION 8 & 15 RECEIVED
- 22 Feb 2011 — REGISTERED-PRINCIPAL REGISTER
- 18 Jan 2011 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Jan 2011 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 14 Jan 2011 — ASSIGNED TO LIE
- 10 Jan 2011 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Jan 2011 — STATEMENT OF USE PROCESSING COMPLETE